Company intelligence / Profile preview

DWC Pharmaceutical consulting

Ownership: Private
Development stage: Other

Overview

DWC is a pharmaceutical consulting firm providing regulatory compliance, cGMP and clinical support for both innovative and generic small molecule products. The company specializes in supporting all phases of clinical and commercial production with particular expertise in Japanese regulatory requirements. Its team consists of former industry experts with extensive experience across global markets including the US, EU, Japan, Middle East, India, China, South Korea and Taiwan. Services include audit preparation (GLP/GCP/GMP), due diligence audits for M&A or compliance readiness projects as well as staffing key quality assurance/regulatory affairs roles

Modalities: Small molecule
Industry: Consulting

Partnerships

Lachman Consultants Inc.Validant

Beyond the preview

Go deeper on DWC Pharmaceutical consulting.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on DWC Pharmaceutical consulting.

Explore the full profile